WeVote
Log In

Bill

Bill

SB 386

Civil procedure: civil actions; action for medical monitoring for individuals exposed to a proven toxic substance; provide for. Amends secs. 20126 & 20140 of 1994 PA 451 (MCL 324.20126 & 324.20140) & adds sec. 20136.

2025-2026 Regular Session Introduced by Stephanie Chang and 5 co-sponsors

Michigan bill creates civil action allowing toxic exposure victims to sue for court-ordered medical monitoring costs before disease develops, expanding environmental liability.

REFERRED TO COMMITTEE ON ENERGY AND ENVIRONMENT
#civilprocedure:civilactions #environmentalprotection:hazardousproducts #health:hazardousproducts
0
WeVote Research Nonpartisan
Bill Summary · SB 386

Legislative bill overview

SB 386 amends Michigan's environmental protection laws to create a legal pathway for individuals exposed to proven toxic substances to file civil actions seeking court-ordered medical monitoring. The bill adds new provisions to the Natural Resources and Environmental Protection Act, allowing plaintiffs to establish a cause of action when they've been exposed to a toxic substance and can demonstrate a reasonable medical probability of developing future illness.

Why is this important

Medical monitoring lawsuits allow people exposed to environmental toxins to recover costs for ongoing health screening before disease develops, rather than waiting until they're sick to seek damages. This addresses a gap where exposure victims face significant out-of-pocket expenses for preventive medical care and diagnostic testing, and shifts some responsibility to parties responsible for the toxic exposure. The bill could affect how Michigan industries, municipalities, and defendants handle environmental contamination liability.

Potential points of contention

  • Defining "proven toxic substance" and causation standards: The bill must clearly establish what qualifies as "proven" and what level of scientific evidence is required, which could become contentious between plaintiffs' attorneys and defendants claiming standards are too permissive.
  • Burden on defendants and insurance costs: Businesses worry this expands civil liability significantly, potentially creating large classes of claimants and increasing insurance premiums, liability exposure, and litigation costs.
  • Medical monitoring scope and duration: Disputes will likely arise over what monitoring is "reasonable," how long it must be funded, who determines appropriate tests, and whether courts have consistent standards—creating unpredictable costs for defendants.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.